Whitepaper: Drug shortages – why do they happen and how can we stop them?
Posted: 17 February 2020 | NSF International | No comments yet
This whitepaper from NSF looks at the key causes of drug shortages and what we can do to stop them.
With 56 percent of U.S. health care providers reporting to have changed patient care or delayed therapy as a result of drug shortages, this white paper from NSF looks at the key reasons behind the issue and what you can do to stop it.
Related content from this organisation
- On-demand webinar: Outsourcing selected areas of the quality system
- Whitepaper: Management of change under pressure and how to communicate with regulators in challenging times
- On-demand webinar: Managing your pharmaceutical quality system with 50 percent fewer staff
- On-demand webinar: Remote and virtual GMP audits
- Whitepaper: Drug shortages – why do they happen and how can we stop them?
Related topics
Biopharmaceuticals, Formulation, Manufacturing, QA/QC, Research & Development (R&D)
